Aptuit, Inc. and Siena Biotech entered into a strategic partnership under which Siena Biotech will take a minority stake in Aptuit’s operations in Verona, Italy and Aptuit will serve as Siena’s provider of choice for its development pipeline. The two companies will work collaboratively on the development of Siena’s pipeline of compounds focused on Alzheimer’s disease, Huntington’s disease and oncology. Financial terms were not disclosed. “We are delighted to strengthen our existing relationsh...